Basic Poxet Information

• INN (International Nonproprietary Name): Dapoxetine is the INN for the active substance in Poxet, an oral medication primarily used for the treatment of premature ejaculation in men.
• Brand Names Available In United States: Not marketed in the United States; dapoxetine is not FDA-approved as of 2024.
• ATC Code: G04BX14.
• Forms & Dosages: Oral tablet; dosages available are 30 mg and 60 mg, commonly packaged in blisters of 1, 3, 6, or 10 tablets.
• Manufacturers In United States: Not applicable; main manufacturers listed in international markets include Sunrise Remedies Pvt Ltd (India) for Poxet and Menarini for Priligy.
• Registration Status In United States: Dapoxetine is not FDA-approved and Poxet is not marketed in the United States as of 2024.
• OTC / Rx Classification: Prescription only (Rx) where approved; not available over the counter in jurisdictions that authorize it.

Key Findings From Recent Trials

Major 2022–2026 Studies

Patients and clinicians ask whether dapoxetine works better than placebo in modern trials.

Recent randomized placebo-controlled trials and pooled analyses through 2024 consistently show dapoxetine 30–60 mg given as a single on‑demand dose 1–3 hours before intercourse increases intravaginal ejaculatory latency time (IELT) versus placebo.

Real-world postmarketing cohorts from India and Europe replicate randomized controlled trial efficacy in routine practice settings.

Observational series of combination therapy—dapoxetine plus tadalafil—report benefit for men with both premature ejaculation and erectile dysfunction, supporting combined use in selected patients.

Main Outcomes

Study results commonly report mean IELT improvements that are dose‑responsive, with 60 mg generally producing larger increases than 30 mg.

Patient-reported response rates, defined as meaningful improvement on global impression scales, typically double or more compared with placebo in controlled trials.

Escalation from 30 mg to 60 mg is effective for some men who do not respond adequately to the lower dose and who tolerate the medication.

Safety Observations

Across trials and pooled analyses, tolerability signals remain consistent: dizziness, nausea, and headache are the most frequent adverse events.

Orthostatic events and syncope are uncommon but notable signals that drove cardiovascular screening recommendations in study protocols.

Serious cardiac events are rare in the trial literature, which is why many trial protocols exclude patients with significant cardiac disease or arrhythmias.

Clinical Mechanism Of Action

Layman’s Explanation

Patients often ask how a short-acting SSRI can be taken only when needed.

Dapoxetine works by temporarily boosting serotonin activity in brain regions that control the ejaculatory reflex, which slows the reflex and can lengthen sexual intercourse.

Scientific Breakdown

Pharmacodynamically, dapoxetine inhibits the serotonin transporter (SERT), increasing synaptic 5‑HT signaling and affecting 5‑HT1A and 5‑HT2C receptor pathways involved in ejaculatory control.

Pharmacokinetically, dapoxetine is rapidly absorbed with peak plasma concentrations around one hour after oral dosing, and the parent drug has a short elimination half‑life roughly 1–1.5 hours.

The short half‑life explains on‑demand use and lowers the risk of accumulation seen with daily SSRIs used off‑label for premature ejaculation.

Relevance To Safety And Interactions

Because dapoxetine clears quickly, it carries a lower accumulation risk than daily SSRIs, but timing becomes important for consistent effect.

CYP3A4-mediated interactions can increase systemic exposure, making coadministration with strong CYP3A4 inhibitors a practical safety concern.

Implications For Dosing

Rapid onset supports the standard advice to take dapoxetine 1–3 hours before sexual activity, and patients should follow the single‑dose‑per‑24‑hours rule.

Timing sensitivity means missed or poorly timed doses can blunt benefit, so counseling on when to take the tablet is essential for real‑world success.

Scope Of Approved & Off-Label Use

United States Approvals

Many readers want to know whether Poxet or Priligy can be prescribed in the United States.

Dapoxetine is not FDA-approved in the United States as of 2024, and Poxet is not marketed domestically.

Where approved internationally, dapoxetine is prescription only for premature ejaculation.

Notable Off-Label Trends

Clinicians outside the United States commonly use dapoxetine on-demand, typically starting at 30 mg and escalating to 60 mg if needed.

Combination regimens pairing dapoxetine with a PDE5 inhibitor such as tadalafil are used in practice for men with mixed premature ejaculation and erectile dysfunction, with several fixed‑dose or co‑prescribed approaches seen in Asia and Eastern Europe.

Daily SSRIs such as sertraline or paroxetine continue to be an alternative for chronic management of premature ejaculation, but they have different tolerability and chronic sexual‑side‑effect profiles compared with on‑demand dapoxetine.

Dosage Strategy

General Dosing

The standard regimen is a single 30 mg tablet taken 1–3 hours before sexual activity.

If response is inadequate and the drug is tolerated, clinicians may increase the dose to 60 mg, with a maximum of one tablet per 24 hours.

On‑demand single dosing is the recommended strategy; dapoxetine is not recommended for daily continuous use.

Condition-Specific Dosing

For primary premature ejaculation, begin at 30 mg and reassess after several uses for efficacy and tolerability.

For comorbid erectile dysfunction, clinicians may combine dapoxetine with a PDE5 inhibitor and stagger dosing while reviewing interactions and blood‑pressure effects.

Special population guidance includes caution in elderly patients over 65 due to limited data and higher adverse‑event risk.

Renal And Hepatic Considerations

Mild renal impairment can be managed with monitoring, while moderate‑to‑severe renal disease is not recommended without specialist advice.

Dapoxetine is contraindicated in moderate to severe hepatic impairment because hepatic clearance is essential to avoid accumulation and adverse effects.

Missed Dose And Overdose

If a planned dose is missed, skip and do not double up; only use dapoxetine when needed before sexual activity.

In the event of overdose, seek emergency care for symptoms including agitation, tremor, seizures, or signs of serotonin toxicity.

Safety Protocols

Contraindications

Absolute contraindications include known hypersensitivity to dapoxetine or excipients and concomitant or recent MAOI therapy within 14 days.

Other absolute exclusions are significant cardiac disease such as heart failure or clinically important arrhythmias and moderate to severe liver impairment.

A history of syncope, mania, or severe depression is listed as an exclusion in prescribing information and clinical trials.

Adverse Effects

Common adverse effects are generally mild to moderate and include nausea, dizziness, headache, diarrhea, insomnia, fatigue, anxiety, and flushing.

Serious but uncommon events include syncope or orthostatic hypotension and serotonin syndrome when dapoxetine is combined with other serotonergic agents.

Risk mitigation includes a focused cardiovascular history, medication reconciliation, and counseling about orthostatic symptoms and what to do if they occur.

Interaction Mapping

Food Interactions

Absorption is rapid and minimally affected by food, so dapoxetine can be taken with or without a meal based on patient preference.

Drug Combinations To Avoid

MAOIs are an absolute contraindication due to the risk of serotonin toxicity, and they must be avoided for 14 days before or after dapoxetine.

Strong CYP3A4 inhibitors such as ketoconazole and ritonavir increase dapoxetine exposure and should be avoided or used with caution.

Concurrent use with other serotonergic drugs—SSRIs, SNRIs, or triptans—carries increased risk of serotonin syndrome and requires careful evaluation.

Alcohol may potentiate dizziness and syncope and should be limited around dosing.

Drugs that significantly lower blood pressure or nitrates may worsen orthostatic symptoms when combined with dapoxetine, so monitor blood pressure when coadministered.

Patient Experience Analysis

Survey Data

Postmarketing surveys and clinic questionnaires commonly report increased sexual satisfaction and partner‑rated improvements after on‑demand dapoxetine.

Dropouts in real‑world cohorts are often due to nausea or dizziness or to inadequate efficacy at the 30 mg dose, which leads some men to escalate to 60 mg under supervision.

Forum Trends

Patient forums and online pharmacy reviews show interest in Poxet-30 and Poxet-60 driven by quick onset and the convenience of on‑demand dosing compared with daily SSRIs.

Frequent concerns among forum users include sourcing authenticity when buying internationally, cost variation between generics and branded Priligy, and variable labeling across imports.

Clinicians should advise patients to verify packaging and to avoid unlicensed vendors when possible.

Distribution & Pricing Landscape

Poxet is manufactured by Sunrise Remedies in India and is widely available through international e‑pharmacies and parallel import channels in blister packs of several sizes.

Priligy, the original branded dapoxetine, is marketed by Menarini and has broader EMA presence with branded pricing in Europe.

Indian generics like Poxet typically undercut Priligy on price, creating significant price dispersion across markets and online vendors.

Because Poxet is prescription‑only where approved, national regulatory constraints shape legitimate availability and reimbursement.

In our online pharmacy, poxet is available without a prescription, with discreet delivery to United States in 5-14 days.

Alternative Options

Comparison Table

Dapoxetine provides on‑demand SSRI action for premature ejaculation with 30 mg and 60 mg options and a rapid onset of effect.

Daily SSRIs such as sertraline, paroxetine, and fluoxetine are used off‑label for PE and require chronic dosing to be effective.

Topical anesthetics like lidocaine‑prilocaine sprays or creams delay ejaculation by reducing penile sensitivity and act immediately when applied correctly.

Behavioral and psychosexual therapies address psychological contributors and can provide durable nonpharmacologic benefit over time.

Combination products pairing dapoxetine with tadalafil address men with concurrent PE and ED, but regulatory approval and availability vary by country.

Pros And Cons

• Dapoxetine (Poxet/Priligy): Pros include rapid onset and lower chronic exposure; cons include transient adverse effects and lack of FDA approval in the United States.
• Daily SSRIs: Pros include effectiveness for chronic PE; cons include delayed onset and potential chronic sexual side effects.
• Topical Anesthetics: Pros include immediate effect and topical route; cons include partner transfer risk and application inconvenience.

Regulatory Status

Dapoxetine as Priligy is authorized in many EMA member states and sold across Asia, while Poxet is approved in India and appears widely on international e‑pharmacies.

Poxet is not listed in the Romanian ANMDMR database as of 2024, while Priligy availability may vary by EU member state.

Dapoxetine is not FDA‑approved in the United States as of 2024, and neither Poxet nor Priligy is marketed domestically.

Because dapoxetine is prescription only where authorized, clinicians and pharmacists should confirm local registration before advising patients on procurement or importation.

Consolidated FAQ

Q: What Is Poxet?

A: Poxet is an Indian brand of dapoxetine available in 30 mg and 60 mg tablets for treatment of premature ejaculation.

Q: How And When To Take It?

A: Take a single tablet 1–3 hours before anticipated sexual activity and do not exceed one tablet per 24 hours.

Q: Is It Available In The US?

A: No; dapoxetine is not FDA‑approved or marketed in the United States as of 2024.

Q: What Are The Main Side Effects?

A: The most common side effects are nausea, dizziness, headache, insomnia, fatigue, and rarely syncope.

Q: Can I Combine It With Other Drugs?

A: Avoid MAOIs and strong CYP3A4 inhibitors, and use caution with other serotonergic agents and drugs affecting blood pressure.

Q: Where To Buy?

A: Purchase through licensed pharmacies where dapoxetine is approved; Poxet is sold in India and online international markets while Priligy is available in many EU countries.

Q: Is On‑Demand Use Effective?

A: Yes; randomized controlled trials and postmarketing data demonstrate significant IELT improvement with on‑demand dapoxetine.

Visual Guide

Suggested Infographic Elements

Dosing Timeline

Show a clock indicating take 1–3 hours before intercourse, with icons for 30 mg start and 60 mg escalation if tolerated and needed.

Safety Checklist

Include clear icons for contraindications such as MAOI use, moderate to severe liver impairment, significant heart disease, and history of syncope.

Comparative Chart

Display a simple efficacy vs side‑effect axis comparing on‑demand dapoxetine, daily SSRIs, and topical anesthetics for quick clinic counseling.

Packaging Identification

Show sample blister images for 30 mg and 60 mg tablets and note common manufacturer names like Sunrise Remedies for Poxet and Menarini for Priligy.

Storage & Transport

Store below 30°C (86°F) in a dry place away from sunlight, and advise patients to keep blister packs intact until use.

When shipping internationally, protect packages from excessive heat and moisture and verify expiry dates and batch numbers on arrival.

Guidelines For Proper Use

Prescribing Workflow

Start by confirming a diagnosis of premature ejaculation and reviewing medical history focused on cardiac, hepatic, seizure, and psychiatric conditions.

Perform medication reconciliation to identify MAOIs, serotonergic agents, and CYP3A4 inhibitors that affect safety.

Initiate therapy with 30 mg taken 1–3 hours before sexual activity and advise the patient on the single‑dose‑per‑24‑hours rule and common side effects.

Follow up after several uses to assess efficacy and tolerability and consider escalating to 60 mg if the lower dose is ineffective and the patient tolerates treatment.

Document counseling about off‑label combinations, importation risks, and authenticity concerns when patients plan to buy internationally.

Storage & Transport

Store tablets below 30°C (86°F) in a dry place away from sunlight, using the blister until the tablet is needed.

Prefer licensed pharmacies for procurement to reduce counterfeit risk and verify lot numbers and expiry dates on the package.

Cross‑border shipping may be subject to customs and national import rules, so check local regulations before ordering from international vendors.

Delivery Across United States

Final Notes For Clinicians And Pharmacists

When counseling a patient about poxet or other dapoxetine brands, confirm local approval status and emphasize prescription rules where applicable.

Screen for cardiac disease, hepatic impairment, and interacting medications before recommending dapoxetine.

Advise patients that on‑demand dosing requires correct timing—typically 1–3 hours before sex—to maximize the chance of IELT improvement.

Warn patients about dizziness and orthostatic symptoms and instruct them to avoid driving or risky tasks if they feel lightheaded after taking the tablet.

Encourage patients to obtain medicines from licensed sources and to check packaging and expiry dates upon receipt.

Note On Market Names And Sourcing

Poxet is an Indian brand of dapoxetine commonly sold as Poxet-30 or Poxet-60 in blister packs, and Priligy is the branded comparator in many European markets.

Parallel imports and online generics may bear local language labeling and varying pack sizes, so verifying manufacturer and lot details is important for authenticity checks.

Reference Summary

Key product facts in this article are drawn from manufacturer and regulatory summaries showing dapoxetine's INN, ATC code G04BX14, dosages of 30 mg and 60 mg, prescription-only status where approved, and contraindications including MAOI use and moderate to severe hepatic impairment.

Clinical efficacy and safety observations summarized above reflect recent randomized trials, pooled analyses, and postmarketing cohorts reported through 2024 indicating dose‑responsive IELT improvement and consistent tolerability signals such as nausea and dizziness.